posted by Kristine Grow
on October 25, 2018
WASHINGTON, D.C. – Matt Eyles, president and CEO of America’s Health Insurance Plans (AHIP), issued this statement following the U.S. Department of Health and Human Services’ (HHS) new proposal regarding Medicare drug prices:
Drug prices are out of control, and we commend the Administration for its continued commitment to reduce drug prices, so that no seniors or others who rely on Medicare have to choose between paying their bills and paying for their life-saving medications. As branded drug prices continue to rise, more and more of every health care dollar goes to pay for prescription drugs. And too often, Big Pharma games a broken market to hold on to the monopolies that allow them to charge these high prices. Market-based approaches that increase competition and leverage will help improve the ability to negotiate lower prices for patients and reduce costs for taxpayers. We look forward to participating in the comment period to support solutions and collaboration that will drive better innovation and affordability for Americans.
America’s Health Insurance Plans (AHIP) is the national trade association representing the health insurance community. AHIP’s members provide health and supplemental benefits to millions of Americans through employer-provided coverage, the individual insurance market, and public programs such as Medicare and Medicaid. AHIP advocates for solutions that expand access to affordable health care coverage to all Americans through a competitive marketplace that fosters choice, quality, and innovation. Visit www.ahip.org for more information.